A dual-amplification strategy-intergated SERS biosensor for ultrasensitive hepatocellular carcinoma-related telomerase activity detection

• Published in: Frontiers in bioengineering and biotechnology 2023-01, Vol.10, p.1124441-1124441
• Main Authors: Shen, Kang, Hua, Weiwei, Ge, Shengjie, Mao, Yu, Gu, Yuexing, Chen, Gaoyang, Wang, Youwei
• Format: Article
• Language: English
• Subjects: Bioengineering and Biotechnology; catalytic hairpin assembly; hepatocellular carcinoma; strand displacement amplification; surface-enhanced Raman scattering; telomerase
• ISSN: 2296-4185; 2296-4185
• DOI: 10.3389/fbioe.2022.1124441

Telomerase has been considered as a biomarker for early diagnosis and prognosis assessment of hepatocellular carcinoma (HCC), while the highly sensitive and specific methods remain challenging. To detect telomerase, a novel surface-enhanced Raman scattering (SERS) biosensor was constructed using the dual DNA-catalyzed amplification strategy composed of strand displacement amplification (SDA) and catalytic hairpin assembly (CHA). This strategy relies on the extension reaction of telomerase primer induced by telomerase, forming long-stranded DNAs with repetitive sequence to catalyze the follow-up SDA event. Subsequently, the SDA products can trigger the CHA reaction between the SERS probes (Au-Ag nanocages (Au-AgNCs) modified with hairpin DNA1 and Raman reporters) and capture substrate (Au@SiO array labeled with hairpin DNA2), resulting in the formation of numerous "hot spots" to significantly enhance the SERS signal. Results are promising that the established biosensor presented excellent reproducibility, specificity and sensitivity. Moreover, ELISA was applied as the golden standard to verify the application of the proposed biosensor in real samples and the results confirmed the satisfactory accuracy of our method. Therefore, the proposed SERS biosensor has the potential to be an ideal tool for the early screening of HCC.